Physician profile
John Patrick Favero
NPI 1750542197
$17,098.19
in general payments reported to CMS, 2019-2025
71 companies · $3,140 in 2025
The $3,140 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,479 · 2020: $2,112 · 2021: $2,117 · 2022: $1,865 · 2023: $2,555 · 2024: $2,831 · 2025: $3,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,501 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,500.89 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,105.65 | 2019-2025 | |
| Novo Nordisk INC | $1,548.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,174.35 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,111.59 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $970.97 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $880.90 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $761.09 | 2020-2025 | Rexulti, Nuedexta |
| Amgen INC. | $603.65 | 2019-2025 | Repatha, Otezla, Repatha |
| Sunovion Pharmaceuticals INC. | $561.94 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $498.87 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $490.15 | 2019-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $404.96 | 2019-2025 | Spravato |
| Lundbeck LLC | $399.31 | 2020-2025 | Rexulti, Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $381.53 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $356.31 | 2019-2025 | Veozah |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $313.52 | 2019-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.13 | 2019-2025 | Jardiance |
| Abbott Laboratories | $285.72 | 2022-2025 | Freestyle Libre 3 |
| Mylan Specialty L.P. | $281.59 | 2021-2024 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $220.48 | 2024-2025 | Caplyta |
| Dexcom, INC. | $210.30 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $199.49 | 2021-2025 | |
| Allergan, INC. | $194.75 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $194.35 | 2019-2024 | |
| Ironwood Pharmaceuticals, INC | $187.34 | 2019-2024 | Linzess |
| Phathom Pharmaceuticals, INC. | $186.15 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $169.40 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $168.50 | 2021-2024 | Contrave, Onzetra Xsail, Nexletol |
| Kowa Pharmaceuticals America, INC. | $163.88 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $151.71 | 2019-2023 | |
| Nestle Healthcare Nutrition INC. | $121.68 | 2020-2023 | |
| Aimmune Therapeutics, INC. | $108.86 | 2024 | |
| Alkermes, INC. | $100.79 | 2023 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $92.63 | 2024-2025 | Fanapt, Hetlioz |
| Ardelyx, INC. | $87.30 | 2024-2025 | Ibsrela |
| Esperion Therapeutics, INC. | $83.70 | 2021-2022 | |
| Biogen, INC. | $78.19 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $67.30 | 2019-2025 | Ajovy |
| Eisai INC. | $65.03 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.03 | 2022 | |
| Xeris Pharmaceuticals, INC. | $49.52 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $49.01 | 2020-2025 | Qelbree |
| Lexicon Pharmaceuticals, INC. | $49.00 | 2024 | |
| Exact Sciences Corporation | $46.44 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Genentech USA, INC. | $45.02 | 2019-2021 | |
| Corium, LLC | $43.05 | 2022-2023 | Adlarity |
| Impel Pharmaceuticals INC. | $32.53 | 2023 | Trudhesa |
| Ani Pharmaceuticals, INC. | $31.30 | 2025 | Purified Cortrophin Gel |
| Phadia US INC. | $30.06 | 2024 | Immunocap |
| Medtronic, INC. | $27.92 | 2022-2025 | Synchromedii |
| Axonics, INC. | $27.54 | 2022 | |
| Idorsia Pharmaceuticals US INC | $26.16 | 2022-2023 | Quviviq |
| Grifols USA, LLC | $24.48 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $22.64 | 2025 | Neffy |
| Axsome Therapeutics, INC. | $18.10 | 2024 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $17.79 | 2021 | |
| Insulet Corporation | $17.03 | 2024 | Omnipod |
| Tandem Diabetes Care, INC. | $16.69 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Verona Pharma, INC. | $16.46 | 2025 | Ohtuvayre |
| Collegium Pharmaceutical, INC. | $16.40 | 2020 | |
| Tactile Systems Technology INC | $16.26 | 2024 | Flexitouch Plus, Entre Plus |
| Organon LLC | $15.90 | 2024 | |
| Seqirus USA INC | $15.73 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Recordati_rare_diseases_inc. | $15.18 | 2025 | Isturisa |
| Kaleo, INC. | $14.21 | 2022 | |
| Sanofi Pasteur INC. | $13.95 | 2019 | |
| Daiichi Sankyo INC. | $13.12 | 2019 | |
| Shire North American Group INC | $12.63 | 2019 | |
| Medtronic Minimed, INC. | $12.23 | 2020 | |
| Vifor Pharma, INC. | $12.04 | 2021 | |
| Metacel Pharmaceuticals LLC | $7.74 | 2022 |
Drugs and devices associated with these payments
Rexulti $771Ozempic $547Rybelsus $504Nurtec Odt $475Vraylar $410Ubrelvy $356Linzess $331Mounjaro $328Jardiance $324Zavzpret $303Qulipta $288Comirnaty $275Farxiga $274Wegovy $274Breztri $262Aristada $247Freestyle Libre 3 $243Xifaxan $240Trelegy Ellipta $239Repatha $232Prevnar 20 $231Caplyta $220Lybalvi $218Otezla $217Zepbound $198Creon $188Voquezna $186Abrysvo $181Eliquis $160Viberzi $158Vyepti $149Dexcom G6 Transmitter $142Arexvy $142Zenpep $140Trintellix $138Yupelri $131Spravato $130Kerendia $127Shingrix $116Airsupra $113Veozah $104Contrave $98.07Fanapt $92.63Ibsrela $87.30Onzetra Xsail $81.99Evenity $74.48Trumenba $65.05Gardasil 9 $64.96Hetlioz $62.14Paxlovid $59.38Prolia $58.77Emgality $54.94Prevnar 13 $50.31Vaxelis $46.88Vaxneuvance $46.88Belsomra $46.27M-M-R II $33.26Trudhesa $32.53Capvaxive $31.70Purified Cortrophin Gel $31.30Immunocap $30.06Kisunla $29.27Adlarity $28.68Premarin $28.33Estring $28.33The Cologuard Plus Collection Kit $27.29Nexletol $25.00Qelbree $24.66Neffy $22.64Ajovy $20.07Trulance $19.93Cologuard Collection Kit $19.15Entresto $18.43Auvelity $18.10Enflonsia $18.08Gardasil $17.90Omnipod $17.03T:Slim X2 Insulin Pump With Control-Iq $16.69Ohtuvayre $16.46Flexitouch Plus $16.26Entre Plus $16.26Leqvio $15.91Nexplanon $15.90Flucelvax Quadrivalent $15.73Fluad Quadrivalent $15.73Synchromedii $15.50Rotateq $15.36Isturisa $15.18Duavee $14.26Toujeo $14.24Myfembree $14.07Proquad $13.62Quviviq $13.19Fasenra $13.06Nuedexta $9.09
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Favero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.